Clinical Roundup Immunotherapy drugs rapidly reach patients after approval – The Cancer Letter Publications
|
Clinical Roundup Immunotherapy drugs rapidly reach patients after approval
The Cancer Letter Publications The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study. The finding suggests that cancer immunotherapies are adopted at a … |
